The following represents disclosure information provided by authors of this abstract. The Genitourinary Cancers Symposium Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Optimal testosterone suppression on medical ADT should strive to suppress free testosterone levels to levels similar to orchiectomy: What is that value?
Evan Y. Yu
Research Funding - GTx
Robert H. Getzenberg
Research Funding - GTx
Jordan Smith
Employment or Leadership Position - GTx
Michael L. Hancock
Employment or Leadership Position - GTx
Stock Ownership - GTx
Matthew Raymond Smith
Consultant or Advisory Role - GTx
Honoraria - GTx
Research Funding - GTx
S. Bruce Malkowicz
Research Funding - GTx
Paul Sieber
Research Funding - GTx
James T. Dalton
Employment or Leadership Position - GTx
Stock Ownership - GTx
Mitchell S. Steiner
Employment or Leadership Position - GTx
Stock Ownership - GTx (B)